OPTIFEN Dolo Junior susp 100 mg/5ml fl 200 ml
7680671300017
CH-67130
M01AE01
07.10.1.
Active substances:
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6713001
- CPT
- -
- Packaging group
- 200
- Unit
- ml
- Composition
- Suspension: ibuprofenum 100 mg, glycerolum, xanthani gummi, maltitolum liquidum 1447.5 mg, polysorbatum 80, acidum citricum monohydricum, aromatica (Kirsche) cum propylenglycolum, saccharinum natricum, E 219 9 mg, propylis parahydroxybenzoas natricus 1 mg, aqua purificata, ad suspensionem pro 5 ml corresp. natrium 1.86 mg.
Articles (1)
Optifen Dolo Junior 100 mg / 5ml, Suspension zum Einnehmen
suspension
200
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ibuprofenum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
glycerolum
|
- | Substance | HNIDK |
|
xanthani gummi
|
- | Substance | HNIDK |
|
maltitolum liquidum
|
1447.5 MG | Substance | HBESI |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
propylenglycolum
|
- | Substance | HBESI |
|
saccharinum natricum
|
- | Substance | AIMDK |
|
E 219
|
9.0 MG | Substance | HBESI |
|
propylis parahydroxybenzoas natricus
|
1.0 MG | Substance | HBESI |
|
aqua purificata
|
- | Substance | HNIDK |
|
natrium
|
1.86 MG | Substance | HBESI |
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 67130
- Drug name
- Optifen Dolo Junior, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- M01AE01
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 02/05/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.10.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OPTIFEN Dolo Junior susp 100 mg/5ml fl 200 ml
- Description (DE)
- OPTIFEN Dolo Junior Susp 100 mg/5ml Fl 200 ml
- Market launch
- 02/05/2019
- Narcotic (BTM)
- No